Skip directly to search Skip directly to A to Z list Skip directly to site content
CDC Home

Volume 11, Number 6—June 2005


Community-associated Methicillin-resistant Staphylococcus aureus in Hospital Nursery and Maternity Units

Simona Bratu*, Antonella Eramo†, Robert Kopec‡, Elizabeth Coughlin‡, Monica Ghitan‡, Robert Yost‡, Edward K. Chapnick‡, David Landman*Comments to Author , and John Quale*
Author affiliations: *State University of New York-Downstate, Brooklyn, New York, USA; †Long Island College Hospital, Brooklyn, New York, USA; ‡Maimonides Medical Center, Brooklyn, New York, USA

Main Article

Table 1

Clinical information for patients with methicillin-resistant Staphylococcus aureus infection during the outbreak period

Patient Age at onset Sex Strain Infection type Initial therapy Definitive therapy
P1, newborn 8 d F USA 400 Preseptal cellulitis Nafcillin, cefotaxime Topical gentamicin
P2, newborn 13 d F USA 400 Omphalitis, otitis externa Ampicillin, cefotaxime Topical mupirocin
P3, mother 33 y F USA 400 Breast abscess Cefazolin Surgical drainage, vancomycin, topical mupirocin
P4, newborn 2 d M USA 400 Omphalitis, pustulosis Nafcillin Gentamicin Gentamicin, topical mupirocin
P5, newborn 4 d M USA 400 Pustulosis Cephalexin Topical bacitracin
P6, newborn 2 d M USA 400 Pustulosis None Local wound care
P7, newborn 1 d F USA 400 Pustulosis, mastitis Topical mupirocin Vancomycin
P8, mother 24 y F Unique Peripheral IV catheter site Cefazolin Trimethoprim-sulfamethoxazole, catheter removal

Main Article

Top of Page The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Rd. Atlanta, GA 30333, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC–INFO